Announcement on Canceling Some Restricted Stocks Granted and Not Yet Vested
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Canceling Some Restricted Stocks Granted and Not Yet Vested
Filed with SSE · · 4 pages · Chinese
Release
Beijing Hotgen Biotech Co. Ltd. on 6ix
Earlier from Beijing Hotgen Biotech
- Announcement on Voluntary Disclosure of Obtaining the "Acceptance Notice" for Clinical Trial Application for Subsidiary’s Innovative Drug SGT003 Injection
- Announcement on Progress in Disposal of Repurchased Shares
- Announcement on Initial Sale of Repurchased Shares Through Call Auction
- Announcement on Voluntary Disclosure of Completion of the First Patient Enrollment and Dosing in the Phase II Clinical Trial of SGC001 Innovative Drug by a Subsidiary
- Announcement on Voluntary Disclosure of the Completion of First Patient Enrollment and Dosing in the Phase Ib Clinical Trial of Innovative Drug AA001 Monoclonal Antibody for Alzheimer’s Disease by an Joint-stock Company
Later from Beijing Hotgen Biotech
- Announcement on Progress and Implementation Result of Shares Repurchase and Share Changes
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Capital Increase of Joint Stock Company and Related Party Transactions
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Serious Abnormal Fluctuations in Stock Trading
Follow Beijing Hotgen Biotech into a list and get an email when it puts out news.
Follow Beijing Hotgen Biotech